Lakeside Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lakeside Advisors's PFE Position: Q3 2026 in Review
Lakeside Advisors increased its Pfizer (PFE) stake by 7.1% in Q3 2026, buying an estimated $19.5K and bringing the position to 11,027 shares worth $314K. The position accounts for 0.18% of the portfolio, ranked #59.
Lakeside Advisors first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $325K in Q4 2021. 2,277 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Lakeside Advisors held 11,027 shares of Pfizer worth $314K as of Q3 2026.
- Lakeside Advisors bought 734 Pfizer shares in Q3 2026, an estimated $19.5K.
- Pfizer made up 0.18% of Lakeside Advisors's portfolio in Q3 2026, its #59 holding.
- Lakeside Advisors first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- Lakeside Advisors's Pfizer position peaked at $325K in Q4 2021.
- 2,277 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Lakeside Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.